New Drugs Are Coming to Fight Nasty Flu Seasons
- Shionogi, Roche prepare to sell new anti-flu drug this year
- More alternatives seen boosting market to $1.2 billion by 2025
Flu Expected to Kill 50,000 in U.S.
This article is for subscribers only.
Flu has been on a vicious march this winter, evading vaccines, overwhelming hospitals and prompting school closures from California to Hong Kong in its wake. But relief in the form of new drugs is on the way.
Almost two decades after Roche Holding AG’s Tamiflu first reached pharmacy shelves, researchers around the world are pushing ahead with a raft of new options. None will arrive in time to help sufferers this winter, but the most advanced -- developed by Roche and Shionogi & Co. -- could be on the market in Japan within months and available in the U.S. and Europe next winter.